- Award builds on JKTG-funded work of Johns Hopkins’ Researcher, Robert Ivkov, Ph.D.
February 26, 2018 / HIGHLAND, MD – The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG) today announced a second round of funding to Robert Ivkov, M.Sc., Ph.D., at Johns Hopkins’ University Kimmel Cancer Center, for continued research on the use of nanoparticles and the immune system to fight cancers.
“Rob’s work questions traditional research approaches and has great potential to change how we think about cancer treatment,” said Ted Giovanis, founder and president of the JKTG Foundation.
“JKTG believes emerging research must ask questions without knowing the answer, and thereby finds revolutionary solutions. Rob’s first stage of research has done just that and we’re excited to build on those prior results by funding this next phase.”
JKTG funded initial research in which Ivkov applied his expertise in materials engineering to develop ultra-tiny structures often called nanoparticles. Nanoparticles are one million times smaller than a human cell and Ivkov’s intent by studying nanomedicine, as it relates to cancer, is to develop nanoparticles that will direct the immune system to fight the disease.
His innovative approach causes nanoparticles with an antibody attached to bind to cells in tumors. These tiny machines can then be activated to stimulate immune cells with heat much like a local fever which then attack the cancer cells.
The new research will also investigate other aspects of the stimulation of the immune system. The hope is that this process re-engages the immune system to fight the cancer cells and win.
About the JKTG Foundation
The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) aims to change health care for the better. Funding innovative medical research, data analysis, events and other projects, the Foundation serves as an honest, independent broker of ideas and actions designed to advance both health care and health policy. Visit www.jktgfoundation.org to learn more.
MEDIA CONTACT: Amy Lee / 202.280.8816 / [email protected]
Featured news
Ted’s Take: Do we need AI guardrails?
Artificial Intelligence (AI) is all the rage now. There are all numbers of folks developing AI technology and applications that range from simple to complex.
Ted’s Take: Does AI learn and incorporate our biases?
We hear tons of conversation around the use of Artificial Intelligence (AI). We also hear that the application of AI might be the solution to almost everything. While that’s both an overstatement and unrealistic, there are a lot of companies and folks working to make AI do just that — solve everything
Ted’s Take: Errors in formulas and what it means for AI
Spinach is the best source of iron. I’ve understood this for decades now. As I ate more and more healthy foods, I’d choose spinach salads because of the “great” nutritional value, particularly iron.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133